At MidValley Healthcare, we provide treatment for those dealing with opiate abuse and dependence.
There is a new drug potentially coming to market that is pure morphine and pure oxycodone. The FDA is holding hearings today to discuss whether or not this new medication will be approved. If approved, MoxDuo would be the first combination drug including two immediate-release opioids.
It seems that some pain experts are glad to have this new option because of some benefits it may have; however, addiction specialists are less sure that the benefits will outweigh the risks.
This will be a story to follow in the coming weeks and months as we work to help clients obtain and maintain sobriety.